Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

K Gao, R Wang, J Chen, L Cheng, J Frishcosy… - Chemical …, 2022 - ACS Publications
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …

Computer simulation of molecular recognition in biomolecular system: from in silico screening to generalized ensembles

Y Fukunishi, J Higo, K Kasahara - Biophysical Reviews, 2022 - Springer
Prediction of ligand-receptor complex structure is important in both the basic science and the
industry such as drug discovery. We report various computation molecular docking methods …

Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19

HT Kao, A Orry, MG Palfreyman, B Porton - Scientific Reports, 2022 - nature.com
Nsp1 is one of the first proteins expressed from the SARS-CoV-2 genome and is a major
virulence factor for COVID-19. A rapid multiplexed assay for detecting the action of Nsp1 …

Aloin A inhibits SARS CoV-2 replication by targeting its binding with ACE2-Evidence from modeling-supported molecular dynamics simulation

HA Alhadrami, AM Sayed, HM Hassan… - Journal of Biomolecular …, 2023 - Taylor & Francis
The current study aimed to expand on the recently published results and assess the
inhibitory efficacy of aloin A against SARS CoV-2. In vitro testing of aloin A against SARS …

Probing the mechanism of lysosomal activation by naringenin using two signature lysosomal enzymes as entry points

H Lu, Z Li, Y Zhou, H Jiang, H Wang, Y Liu… - Journal of Molecular …, 2023 - Elsevier
Naringenin is a flavonoid substance that is widely used in health products and cosmetics,
among others. Studies have shown that naringenin can activate lysosomes and thus inhibit …

Mechanistic insights of key host proteins and potential repurposed inhibitors regulating SARS‐CoV‐2 pathway

D Pramanik, AB Pawar, S Roy… - Journal of Computational …, 2022 - Wiley Online Library
The emergence of pandemic situations originated from severe acute respiratory syndrome
(SARS)‐CoV‐2 and its new variants created worldwide medical emergencies. Due to the …

Unbinding of hACE2 and inhibitors from the receptor binding domain of SARS-CoV-2 spike protein

L Mishra, T Bandyopadhyay - Journal of Biomolecular Structure …, 2023 - Taylor & Francis
The first direful biomolecular event leading to COVID-19 disease is the SARS-CoV-2 virus
surface spike (S) protein-mediated interaction with the human transmembrane protein …

Identification of inhibitors against SARS-CoV-2 variants of concern using virtual screening and metadynamics-based enhanced sampling

N Mandal, SL Rath - Chemical Physics, 2023 - Elsevier
Among the variants of SARS-CoV-2, some are more infectious than the Wild-type.
Interestingly, these mutations enable the virus to evade the therapeutic efforts. Hence, there …

The Mode of Therapeutic Action of 2-deoxy D-glucose: Anti-Viral or Glycolysis Blocker?

B Ghosh, S Roy, JK Singh - 2021 - chemrxiv.org
Recently an anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) an
analogue of glucose has been developed in collaboration between Institute of Nuclear …